SARS-CoV-2 Antibody Seroprevalence in Patients With Cancer on Systemic Antineoplastic Treatment in the First Wave of the COVID-19 Pandemic in Portugal

At the time of the first wave of the COVID-19 pandemic, patients with cancer were considered to be at high risk of serious illness and had a higher exposure risk since they needed frequent and nondeferrable hospital visits. Serological tests were not routinely used, and seroprevalence in this popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Gonçalo, Paixão, Paulo, Brum, Laura, Padrão, Teresa, Correia, Jorge, Albuquerque, Joana, Pulido, Catarina, Nave, Mónica, Timóteo, Teresa, Rodrigues, Tânia, Costa, Filipe, Passos-Coelho, José L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901131/
https://www.ncbi.nlm.nih.gov/pubmed/35273890
http://dx.doi.org/10.7759/cureus.22428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901131/
https://www.ncbi.nlm.nih.gov/pubmed/35273890
http://dx.doi.org/10.7759/cureus.22428

Ejemplares similares